000			01762nam a22002297a 4500
999			_c2217 _d2217
003			OSt
005			20191226214828.0
008			111017t xxu||||| |||| 00| 0 eng d
020			_a9241546956
020			_a9789241546959
060			_aWF 310 G 2006
245	0	0	_aGuidelines for the programmatic management of drug-resistant tuberculosis.
260			_aGeneva : _bWorld Health Organization, _c2006.
300			_ax, 174 p. : _c24 cm. _bill. ;
504			_aIncludes bibliographical references.
520			_aThese new guidelines on the programmatic management of drug-resistant tuberculosis represent the best current knowledge in the management of drug-resistant TB and MDR-TB, and offer ample options to tailor diagnosis and care to different epidemiological and programmatic conditions worldwide. The recommendations, compiled by leading experts in the subject, should be followed without hesitation by all national programs and their partners as the most solid programmatic standards. At the same time, it is imperative to stress that the five elements of the DOTS strategy remain the cornerstone of TB control, and the most effective tool to prevent the onset and dissemination of drug resistance. Without the essential elements of TB control fully in place, management of MDR-TB will undoubtedly fail in the long term. These guidelines focus on care for MDR-TB patients, in the hope and expectation that, in future, the occurrence of massive numbers of cases can be prevented through sound TB control practices.--Publisher's description.
650		0	_aTuberculosis
700	1		_aRich, Michael.
942			_2NLM _cWHO PUB